People living with human immunodeficiency virus (HIV) are approximately 30 times more likely to develop tuberculosis (TB) than individuals without HIV. TB is the most common presenting illness among people living with HIV, including those receiving antiretroviral treatment, and the major cause of HIV-related death (1) . The TB-HIV/AIDS epidemic is compounded by the emergence of opportunistic infections with nontuberculous mycobacteria (NTM) in patients with HIV/ AIDS patients, and the treatment for these infections differs from that for TB. In patients with AIDS, the clinical and radiological features of infections with NTM and tuberculous mycobacteria (MTB) are more complex and usually involve different disease patterns and atypical clinical findings, thus limiting the diagnosis of mycobacterial infections in patients infected with HIV (2) (3) . Given the high prevalence of HIV infection in China, there is a growing concern that NTM and other infections could be misdiagnosed as MTB in people infected with HIV. A recent report from Guangxi, China indicated that M. tuberculosis was found in 117 patients infected with HIV (53%) while NTM was found in 102 (47%) (4). The current study has determined the frequency with which MTB and NTM strains were isolated from patients infected with HIV in Shanghai from 2014 to 2016 and the genotype of NTM in this population.
A total of 101 isolates from 2014, 137 from 2015, and 162 from 2016 were subjected to 16S rDNA sequencing to identify the species. Forty-one (41/101, 40.6%) were identified as NTM in 2014, 64 (64/137, 46.7%) were identified as NTM in 2015, and 72 (72/162, 44.4%) were identified as NTM in 2016 ( Figure 1 ). A total of 7 NTM species or complexes were identified from the NTM isolates (Table 1 ). The organism detected most frequently was M. avium complex (MAC), followed by M. gordonae and M. kansasii.
The high frequency of NTM strains found in patients infected with HIV raises concerns about accurate species identification before deciding proper treatment (5) . Failure to characterize acid-fast bacilli (AFB)-positive lung infections caused by NTM has led to the misdiagnosis of these infections and mistreatment for pulmonary TB in developing countries such as China. Treatment is limited because of the difficulty in
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The increased co-incidence of tuberculosis (TB) and AIDS is compounded by the emergence of opportunistic infections with non-tuberculous mycobacteria (NTM) in patients with HIV/ AIDS, and the treatment for these infections differs from that for TB. identifying the species of pathogen up and the resistance of most strains of NTM to conventional anti-MTB drugs (6) . When treated empirically, some NTM infections are misdiagnosed as non-responsive or drug-resistant MTB cases, and this can result in poor outcomes for those patients (7) . Overall, the species of Mycobacteria isolates needs to be rapidly and accurately identified to determine appropriate antibiotic therapy, and this is especially true for patients infected with HIV (8 
